Elite Diagnostic Limited (JMSE:ELITE)
Jamaica · Delayed Price · Currency is JMD 1.300
-0.010 (-0.76%)
At close: Aug 14, 2026
Elite Diagnostic Financials Overview
Financials in millions JMD. Fiscal year is July - June.
Millions JMD. Fiscal year is Jul - Jun.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Revenue Revenue Growth | 867.3 | 867.3 | 853.82 | 821.28 | 755.33 | 624.22 |
Revenue Growth | 1.58% | 1.58% | 3.96% | 8.73% | 21.00% | 23.14% |
Gross Profit Gross Profit Growth | 669.97 | 669.97 | 584.14 | 543.16 | 478.06 | 400.64 |
Operating Income Operating Income Growth | 77.09 | 77.09 | 71.38 | 96.54 | 64.71 | 82.45 |
Net Income Net Income Growth | 31.51 | 31.51 | 32.02 | 26.16 | 13.35 | 48.66 |
Earnings Per Share EPS Growth | 0.09 | 0.09 | 0.09 | 0.07 | 0.04 | 0.14 |
EPS Growth | -0.68% | -0.68% | 22.44% | 95.91% | -72.56% | 2422.72% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Investments Cash & Investments Growth | 124.17 | 124.17 | 225.55 | 37.22 | 53.88 | 75.89 |
Total Debt Total Debt Growth | 676.81 | 676.81 | 472.33 | 454.52 | 544.32 | 401.66 |
Net Cash (Debt) Net Cash Growth | -552.64 | -552.64 | -246.78 | -417.3 | -490.44 | -325.77 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -1.58 | -1.58 | -0.70 | -1.18 | -1.39 | -0.92 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 144.61 | 144.61 | 260.57 | 164.81 | 111.88 | 147.92 |
Capital Expenditures CapEx Growth | -436.85 | -436.85 | -92.62 | -72.53 | -137.75 | -275.79 |
Free Cash Flow Free Cash Flow Growth | -292.24 | -292.24 | 167.95 | 92.29 | -25.87 | -127.87 |
Free Cash Flow Growth | - | - | 81.98% | - | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Gross Margin | 77.25% | 77.25% | 68.41% | 66.14% | 63.29% | 64.18% |
Operating Margin | 8.89% | 8.89% | 8.36% | 11.76% | 8.57% | 13.21% |
Pretax Margin | 3.83% | 3.83% | 4.32% | 3.57% | 1.77% | 7.80% |
Profit Margin | 3.63% | 3.63% | 3.75% | 3.19% | 1.77% | 7.80% |
FCF Margin | -33.70% | -33.70% | 19.67% | 11.24% | -3.43% | -20.48% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 18, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.010 | - | 0.010 | - | - | 0.020 |
Dividend Per Share Growth | 0% | - | - | - | - | -77.78% |
Dividend Yield | 0.77% | - | 0.67% | - | - | 0.57% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 18, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
PE Ratio | 14.44 | 13.57 | 16.66 | 20.94 | 58.50 | 25.71 |
P/FCF Ratio | - | - | 3.18 | 5.94 | - | - |
PS Ratio | 0.53 | 0.49 | 0.63 | 0.67 | 1.03 | 2.00 |